AVTX - Avalo Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
13.99 -0.11 (-0.79%)	---	---	---	0.1 (0.71%)	-0.11 (-0.79%)	---	0.1 (0.71%)

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -1.92
Diluted EPS:: -1.92
Basic P/E:: -7.2292
Diluted P/E:: -7.2292
RSI(14) 1m:: 30.23
VWAP:: 13.89
RVol:: 0.3681

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	13.76 -0.17 (-1.22%)	Oct 15 11:55
1m	Price decrease 1m	13.79 -0.14 (-1.01%)	Oct 15 11:40
1m	Price decrease 1m	13.7 -0.15 (-1.05%)	Oct 15 09:47
1m	Price decrease 1m	13.85 -0.14 (-1.0%)	Oct 15 09:30